302 related articles for article (PubMed ID: 9361071)
1. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptors are detectable in tumor fragment spheroids of meningiomas in vitro.
Tonn JC; Ott MM; Meixensberger J; Paulus W; Roosen K
Anticancer Res; 1994; 14(6B):2453-6. PubMed ID: 7872666
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptors in tumor fragment spheroids of human meningiomas.
Tonn JC; Ott MM; Paulus W; Meixensberger J; Roosen K
Acta Neurochir Suppl; 1996; 65():105-7. PubMed ID: 8738509
[TBL] [Abstract][Full Text] [Related]
4. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
Gursan N; Gundogdu C; Albayrak A; Kabalar ME
Int J Neurosci; 2002 Apr; 112(4):463-70. PubMed ID: 12325398
[TBL] [Abstract][Full Text] [Related]
7. Progesterone Receptor Is Responsible for Benign Biology of Skull Base Meningioma.
Kuroi Y; Matsumoto K; Shibuya M; Kasuya H
World Neurosurg; 2018 Oct; 118():e918-e924. PubMed ID: 30031954
[TBL] [Abstract][Full Text] [Related]
8. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
Waelti ER; Markwalder TM
Surg Neurol; 1989 Feb; 31(2):96-100. PubMed ID: 2522246
[TBL] [Abstract][Full Text] [Related]
9. Progesterone and glucocorticoid receptor activation in meningiomas.
Carroll RS; Zhang J; Dashner K; Black PM
Neurosurgery; 1995 Jul; 37(1):92-7. PubMed ID: 8587697
[TBL] [Abstract][Full Text] [Related]
10. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression.
Nagashima G; Asai J; Suzuki R; Fujimoto T
Brain Tumor Pathol; 2001; 18(1):1-5. PubMed ID: 11517968
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
[TBL] [Abstract][Full Text] [Related]
12. Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones.
Speirs V; Boyle-Walsh E; Fraser WD
Int J Cancer; 1997 Sep; 72(5):714-9. PubMed ID: 9311583
[TBL] [Abstract][Full Text] [Related]
13. The molecular biology of hormone and growth factor receptors in meningiomas.
Black P; Carroll R; Zhang J
Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495
[TBL] [Abstract][Full Text] [Related]
14. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
[TBL] [Abstract][Full Text] [Related]
15. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
[TBL] [Abstract][Full Text] [Related]
16. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ki-67 and p53 in meningiomas.
Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
[TBL] [Abstract][Full Text] [Related]
18. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
19. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel.
Tichomirowa MA; Theodoropoulou M; Daly AF; Yassouridis A; Hansen S; Lu J; Lange M; Goldbrunner RH; Stalla GK; Renner U
Int J Cancer; 2008 Oct; 123(8):1956-63. PubMed ID: 18688857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
